Latest filing published 24 May 2022 for ChemoCentryx, Inc..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Henry A. Mckinnell is a declared insider at 8 companies (board member); the most frequent names are Moodys Corp /DE/, Pfizer Inc and ViewRay, Inc. Between 3 January 2006 and 20 May 2022, the trades on record add up to 124 filings.
Market trades split into 2 purchases (€1.8M) and 1 sale (€5.0M). The net balance comes to €3.2M on the selling side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 105 share grants and 9 option exercises.
The record was last updated on 24 May 2022 with an option exercise in ChemoCentryx, Inc. The latest purchase dates back some time: it was published 3,563 days ago, on 20 January 2017. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations